(Q58647150)

Salvador Iborra

Camila Indiani de Oliveira

15

0 references

Camila Indiani de Oliveira

6

0 references

Aldina Barral

13

Aldina Barral

0 references

Cláudia Brodskyn

12

Claudia Brodskyn

0 references

Manuel Soto

1

Manuel Soto

0 references

author name string

Laura Ramírez

2

0 references

Miguel A. Pineda

3

0 references

Victor M. González

4

0 references

Petter F. Entringer

5

0 references

Ivan P. Nascimento

7

0 references

Ana P. Souza

8

0 references

Laura Corvo

9

0 references

Carlos Alonso

10

0 references

Pedro Bonay

https://api.crossref.org/works/10.3814%2F2009%2F173039

11

0 references

publication date

2009

0 references

volume

2009

0 references

page(s)

1-25

0 references

1 reference

The current status of zoonotic leishmaniases and approaches to disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Cytokine expression during the outcome of canine experimental infection by Leishmania infantum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Molecular biological applications in the diagnosis and control of leishmaniasis and parasite identification

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Serodiagnosis of Leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Recombinant DNA-derived leishmania proteins: from the laboratory to the field

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Second-generation vaccines against leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmaniasis: current status of vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Immunization with Leishmania infantum released proteins confers partial protection against parasite infection with a predominant Th1 specific immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Molecular cloning of the major surface antigen of leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Molecular cloning and characterization of the immunologically protective surface glycoprotein GP46/M-2 of Leishmania amazonensis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Life without transcriptional control? From fly to man and back again

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

More surprises from Kinetoplastida

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Isolation, characterization and analysis of the expression of the Leishmania ribosomal P0 protein genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Molecular characterization of a Leishmania donovani infantum antigen identified as histone H2A

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

During canine leishmaniasis a protein belonging to the 83-kDa heat-shock protein family elicits a strong humoral response

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Identification and characterisation of a Leishmania donovani antigen belonging to the 70-kDa heat-shock protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Immune response regulation by leishmania secreted and nonsecreted antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Evolutionarily conserved proteins as prominent immunogens during Leishmania infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Recent advances in vaccines for leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Immunology of leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Expression cloning of a protective Leishmania antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

DNA vaccines and their application against parasites--promise, limitations and potential solutions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

From genome to vaccines for leishmaniasis: Screening 100 novel vaccine candidates against murine Leishmania major infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Identification of a histone H1-like gene expressed in Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Isolation of genes showing increased or unique expression in the infective promastigotes of Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

A Leishmania major protein with extensive homology to silent information regulator 2 of Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

The molecular biology of the SIR proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Cytoplasmic SIR2 homologue overexpression promotes survival of Leishmania parasites by preventing programmed cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania major: cell type dependent distribution of a 43 kDa antigen related to silent information regulatory-2 protein family.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Identification of antibodies to Leishmania silent information regulatory 2 (SIR2) protein homologue during canine natural infections: pathological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

The surface glycoconjugates of trypanosomatid parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

The major surface protease (MSP or GP63) of Leishmania sp. Biosynthesis, regulation of expression, and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

The promastigote surface protease of Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Characterization of Leishmania donovani antigens encapsulated in liposomes that induce protective immunity in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

gp63 in stable cationic liposomes confers sustained vaccine immunity to susceptible BALB/c mice infected with Leishmania donovani.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Loss of the GP46/M-2 surface membrane glycoprotein gene family in the Leishmania braziliensis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Therapy of murine cutaneous leishmaniasis by DNA vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

DNA vaccines induce partial protection against Leishmania mexicana

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP-11 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Humoral and Cellular Immune Responses to Synthetic Peptides of the Leishmania donovani Kinetoplastid Membrane Protein-11

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Recombinant leishmania antigens for serodiagnosis of visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Characterisation of a second protein encoded by the differentially regulated LmcDNA16 gene family of Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Expression of a hydrophilic surface protein in infective stages of Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Expression of hydrophilic surface proteins in infective stages of Leishmania donovani

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Serodiagnosis of Leishmania donovani infections: assessment of enzyme-linked immunosorbent assays using recombinant L. donovani gene B protein (GBP) and a peptide sequence of L. donovani GBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Expression of cysteine proteinase type I and II of Leishmania infantum and their recognition by sera during canine and human visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Cloning of a Leishmania major gene encoding for an antigen with extensive homology to ribosomal protein S3a.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

The Leishmania HSP20 is antigenic during natural infections, but, as DNA vaccine, it does not protect BALB/c mice against experimental L. amazonensis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania major: molecular cloning, sequencing, and expression of the heat shock protein 60 gene reveals unique carboxy terminal peptide sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania infantum: gene cloning of the GRP94 homologue, its expression as recombinant protein, and analysis of antigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Identification of Leishmania major cysteine proteinases as targets of the immune response in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Interleukin-4 (IL-4) and IL-10 collude in vaccine failure for novel exacerbatory antigens in murine Leishmania major infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Dual role of the Leishmania major ribosomal protein S3a homologue in regulation of T- and B-cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

The Trypanosoma cruzi ribosomal P protein family: classification and antigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Humoral and cell-mediated autoimmune reactions to human acidic ribosomal P2 protein in individuals sensitized to Aspergillus fumigatus P2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Cloning and expression of Trypanosoma cruzi ribosomal protein P0 and epitope analysis of anti-P0 autoantibodies in Chagas' disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

A postgenomic view of the heat shock proteins in kinetoplastids

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania LPG3 encodes a GRP94 homolog required for phosphoglycan synthesis implicated in parasite virulence but not viability

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Cloning and characterization of the Leishmania (Viannia) braziliensis Hsp70 gene. Diagnostic use of the C-terminal fragment rLb70(513-663).

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Analysis of the adjuvant effect of recombinant Leishmania infantum Hsp83 protein as a tool for vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Recombinant antigens for specific and sensitive serodiagnosis of Latin American tegumentary leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Characterization of the immune response to Leishmania infantum recombinant antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB/c mice against a virulent challenge with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania histone H1 overexpression delays parasite cell-cycle progression, parasite differentiation and reduces Leishmania infectivity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Expression of a novel Leishmania gene encoding a histone H1-like protein in Leishmania major modulates parasite infectivity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Protection against cutaneous leishmaniasis in outbred vervet monkeys using a recombinant histone H1 antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

The proteases and pathogenicity of parasitic protozoa

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania major: comparison of the cathepsin L- and B-like cysteine protease genes with those of other trypanosomatids

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Evidence from disruption of the lmcpb gene array of Leishmania mexicana that cysteine proteinases are virulence factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

T helper (h)1/Th2 and Leishmania: paradox rather than paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Th1 cell development induced by cysteine proteinases A and B in localized cutaneous leishmaniasis due to Leishmania guyanensis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Recombinant cysteine proteinase from Leishmania (Leishmania) chagasi implicated in human and dog T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Vaccination with a preparation based on recombinant cysteine peptidases and canine IL-12 does not protect dogs from infection with Leishmania infantum

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Potent stimulation of the innate immune system by a Leishmania brasiliensis recombinant protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

IL-4 Rapidly Produced by Vβ4 Vα8 CD4+ T Cells Instructs Th2 Development and Susceptibility to Leishmania major in BALB/c Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

A comparative evaluation of different DNA vaccine candidates against experimental murine leishmaniasis due to L. major

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Protective immune response against cutaneous leishmaniasis by prime/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

A heterologous prime-boost regime using DNA and recombinant vaccinia virus expressing the Leishmania infantum P36/LACK antigen protects BALB/c mice from cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Identification and overexpression of the A2 amastigote-specific protein in Leishmania donovani.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania chagasi T-cell antigens identified through a double library screen

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Diagnostic value of rK39 dipstick in zoonotic visceral leishmaniasis in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Standardization of a rapid immunochromatographic test with the recombinant antigens K39 and K26 for the diagnosis of canine visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Kinesin motor domain of Leishmania donovani as a future vaccine candidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Molecular determinants and regulation of Leishmania virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Leishmania cytosolic silent information regulatory protein 2 deacetylase induces murine B-cell differentiation and in vivo production of specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039

Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-γ production but does not protect BALB/c mice against Leishmania chagasi intravenous challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.3814%2F2009%2F173039